Generate Biomedicines, Inc. (GENB)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $9.84
- As of
Kresmion compiles this page from GENB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Generate Biomedicines, Inc. (GENB): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-12.
See the full GENB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GENB on one page. Preview it with sample data, then open it live with a free account.
Preview the GENB dossierActive events for GENB
- mediumEarnings below estimates
Q3-2026: Missed consensus by 19.8%, EPS $-0.68 vs $-0.5678 estimate
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 94% of GENB (2026Q2)
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in GENB
- medium13F: new position
TWO SIGMA INVESTMENTS, LP new position in GENB
- medium13F: new position
MILLENNIUM MANAGEMENT LLC new position in GENB
FREE, NO ACCOUNT
Every event on GENB, as it fires
You are seeing 5 of 8 events recorded on GENB since 2026-05-27.
The five above landed across 3 days. The other 3 were recorded on 2 other days. 5 of the 8 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, GENB
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on GENB
Cite this data
Kresmion counts the managers it follows that reported a non-option position in GENB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on GENB in the last 180 days.
Upstream: SEC EDGAR filings for GENB
Kresmion, "Generate Biomedicines, Inc. (GENB) institutional holdings and SEC filings", data as of 2026-11-12, https://kresmion.com/research/GENB. Upstream data: SEC EDGAR filings for GENB.
Link to this data (HTML):
<a href="https://kresmion.com/research/GENB">Generate Biomedicines, Inc. (GENB) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow GENB on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to GENB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.